Antiviral therapy in hepatitis B virus-infected immunotolerant children, exploring a new land
Author(s):
Mohamed Aly Mokhles
Mohamed Aly Mokhles
Affiliations:
Corresponding author. Address: 45 Zahraa El Helmia Towers, Gesr El Suez, Cairo, Egypt. Tel.: +201223407520; fax:+20233370931.
EASL LiverTree™. Mokhles M. Nov 1, 2018; 256722
Prof. Dr. Mohamed Aly Mokhles
Prof. Dr. Mohamed Aly Mokhles

Access to this content is an EASL members and LiverTree™ Privileged Users benefit.

Journal Abstract
References
Discussion Forum (0)
Rate & Comment (0)
This article does not have an abstract to display.
[1]. Shishu Zhu - Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: a pilot open-label randomized study
[2]. N.A. Terrault - AASLD guidelines for treatment of chronic hepatitis B
[4]. U. Poddar - Cure for immune-tolerant hepatitis B in children: is it an achievable target with sequential combo therapy with lamivudine and interferon?
[5]. L. D'Antiga - Combined lamivudine/interferon-alpha treatment in “immunotolerant” children perinatally Infected with hepatitis B: a pilot study
[6]. W.P. Brouwer - Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: a multicenter randomized trial (ARES study)
[7]. G.-J. Li - Sequential combination therapy with pegylated interferon leads to loss of hepatitis B surface antigen and hepatitis B e antigen (HBeAg) seroconversion in HBeAg-positive chronic hepatitis B patients receiving long-term entecavir treatment
[8]. H. Chi - Addition of peginterferon alfa-2B during long-term nucleos(T)ide analogue therapy increases hbeag seroconversion and hbsag decline-week 48 results from a multicenter randomized controlled trial (pegon study)
[9]. P. Lampertico - LP25: Add-on peginterferon ALFA-2A significantly reduces hbsag levels in hbeag-negative, genotype d chronic hepatitis b patients fully suppressed on nucleot(s)ide analogue treatment: The HERMES study
[10]. M. Bourlière - Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial
[11]. Dark side of the moon. Pink Floyd album 1973.
[12]. High hopes. From Pink Floyd album the division bell.1994.
Code of conduct/disclaimer available in General Terms & Conditions

By continuing to browse or by clicking “Accept Terms & all Cookies”, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies